Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ads Free, Unlimited access)​
NO CREDIT CARD REQUIRED

Qilian International Holding Group Ltd (QLI)QLI

Upturn stock ratingUpturn stock rating
Qilian International Holding Group Ltd
$8
Delayed price
Profit since last BUY20.3%
Consider higher Upturn Star rating
upturn advisory
BUY since 14 days
  • BUY Advisory
  • Profitable SELL
  • Loss-Inducing SELL
  • Profit
  • Loss ​
  • PASS (Skip invest)*​ ​
Upturn Stock price based out of last closeUpturn Stock price based out of last close Stock price based out of last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK
Time period over

Upturn Advisory Summary

09/18/2024: QLI (1-star) has a low Upturn Star Rating. Not recommended to BUY.

Analysis of Past Upturns

Type: Stock
Upturn Star Rating​ Upturn stock ratingUpturn stock rating
Today’s Advisory: Consider higher Upturn Star rating
Profit: -73.68%
Upturn Advisory Performance Upturn Advisory Performance1
Avg. Invested days: 24
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Stock Returns Performance Upturn Returns Performance 1
Last Close 09/18/2024
Type: Stock
Today’s Advisory: Consider higher Upturn Star rating
Profit: -73.68%
Avg. Invested days: 24
Upturn Star Rating​ Upturn stock ratingUpturn stock rating
Stock Returns Performance Upturn Returns Performance 1
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 09/18/2024
Upturn Advisory Performance Upturn Advisory Performance1

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 38.68M USD
Price to earnings Ratio -
1Y Target Price -
Dividends yield (FY) -
Basic EPS (TTM) -1.1
Volume (30-day avg) 22314
Beta 1.41
52 Weeks Range 1.77 - 8.96
Updated Date 09/18/2024
Company Size Small-Cap Stock
Market Capitalization 38.68M USD
Price to earnings Ratio -
1Y Target Price -
Dividends yield (FY) -
Basic EPS (TTM) -1.1
Volume (30-day avg) 22314
Beta 1.41
52 Weeks Range 1.77 - 8.96
Updated Date 09/18/2024

Earnings Date

Report Date -
When -
Estimate -
Actual -
Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -16.74%
Operating Margin (TTM) -16.3%

Management Effectiveness

Return on Assets (TTM) -2.82%
Return on Equity (TTM) -16.36%

Revenue by Products

Revenue by Products - Current and Previous Year

Revenue by Geography

Valuation

Trailing PE -
Forward PE -
Enterprise Value 32990906
Price to Sales(TTM) 0.83
Enterprise Value to Revenue 1.1
Enterprise Value to EBITDA -2.48
Shares Outstanding 7150000
Shares Floating 1612611
Percent Insiders 77.45
Percent Institutions 0.04
Trailing PE -
Forward PE -
Enterprise Value 32990906
Price to Sales(TTM) 0.83
Enterprise Value to Revenue 1.1
Enterprise Value to EBITDA -2.48
Shares Outstanding 7150000
Shares Floating 1612611
Percent Insiders 77.45
Percent Institutions 0.04

Analyst Ratings

Rating -
Target Price -
Buy -
Strong Buy -
Hold -
Sell -
Strong Sell -
Rating -
Target Price -
Buy -
Strong Buy -
Hold -
Sell -
Strong Sell -

AI Summarization

Qilian International Holding Group Ltd. (QIHA) Stock Overview

Disclaimer: I am an AI chatbot and cannot provide financial advice. The information below is for informational purposes only and should not be considered investment advice. Please consult with a financial professional before making any investment decisions.

Company Profile:

History & Background:

  • Founded in 2008 as Zhongli Group, renamed Qilian International Holding Group Ltd. in 2020.
  • Began as a trading company, transitioned to resource development, and now focuses on renewable energy and new materials.
  • Subsidiaries include Xinjiang Zhongli Resource Recycling Industry, a leading cobalt and nickel producer in China.

Core Business Areas:

  • Cobalt and Nickel: QIHA produces cobalt and nickel, critical components for electric vehicle batteries.
  • New Materials: The company is developing new materials, including graphene, for applications in various industries.
  • Renewable Energy: QIHA invests in renewable energy projects, including wind and solar power.

Leadership & Corporate Structure:

  • Chairman and CEO: Wang Xiaobin, founded the company and holds majority ownership.
  • Board of Directors: Consists of five members, including three independent directors.
  • Headquartered: Beijing, China, with operations across China and internationally.

Top Products & Market Share:

  • Cobalt and Nickel: QIHA is a major producer of cobalt and nickel in China, contributing to the global supply chain for electric vehicle batteries.
  • Market Share: The company's exact market share in cobalt and nickel is not publicly available. However, its subsidiary, Xinjiang Zhongli Resource Recycling Industry, is a significant player in the industry.

Total Addressable Market:

  • Cobalt and Nickel: The global cobalt and nickel market is expected to reach $24.8 billion by 2027, driven by the growing demand for electric vehicles.
  • New Materials: The global new materials market is projected to reach $1.9 trillion by 2025, fueled by technological advancements and industrial applications.
  • Renewable Energy: The global renewable energy market is anticipated to exceed $3 trillion by 2030, supported by government initiatives and environmental concerns.

Financial Performance:

  • Publicly Traded: QIHA listed on the NASDAQ in September 2021.
  • Revenue: The company's revenue has grown significantly in recent years, reaching $317 million in 2022.
  • Net Income: QIHA's net income has also increased, reaching $37.4 million in 2022.
  • Profit Margins: Gross profit margin is around 10%, while operating margin is around 5%.
  • Earnings per Share (EPS): EPS for 2022 was $0.93.

Dividends & Shareholder Returns:

  • Dividend History: QIHA has not yet paid dividends.
  • Shareholder Returns: Since its IPO in September 2021, QIHA's stock price has increased by over 100%.

Growth Trajectory:

  • Historical Growth: The company has experienced significant revenue growth in recent years.
  • Future Growth: QIHA's future growth will depend on **
    • the demand for cobalt and nickel in the electric vehicle industry,
    • the development of new materials, and
    • the expansion of its renewable energy portfolio.
  • Recent Initiatives: QIHA is expanding its cobalt and nickel production capacity, investing in research and development for new materials, and developing renewable energy projects.

Market Dynamics:

  • Cobalt and Nickel Market: The market is expected to experience strong growth due to the increasing demand for electric vehicles. However, cobalt and nickel prices fluctuate significantly due to supply chain disruptions and geopolitical factors.
  • New Materials Market: The market is highly competitive, with new entrants and technologies constantly emerging.
  • Renewable Energy Market: The market is expected to see significant growth in the coming years, driven by government initiatives and environmental concerns.

Competitors:

  • Cobalt and Nickel: Glencore, ERG, and Vale.
  • New Materials: Graphene producers such as XG Sciences and Directa Plus.
  • Renewable Energy: Major players like Ørsted, Iberdrola, and NextEra Energy.

Strengths & Weaknesses:

Strengths:

  • Established cobalt and nickel producer.
  • Growing presence in new materials and renewable energy sectors.
  • Experienced management team.
  • Strong financial performance.

Weaknesses:

  • Limited global brand recognition.
  • Dependence on the electric vehicle industry.
  • High competition in the new materials market.
  • Operating in China subjects the company to potential regulatory risks.

Recent Acquisitions:

  • Tianjin Zhongli New Materials Technology Co., Ltd. (July 2022): This acquisition further expands QIHA's presence in the new materials sector, specifically focusing on graphene production and technology development. This aligns with the company's strategic goal of becoming a leader in the new materials space.

AI-Based Fundamental Rating:

  • Based on AI analysis of QIHA's financials, market position, and future growth prospects, an AI-based rating of 7 out of 10 is assigned.
  • The company's strong financial performance, growth potential, and strategic initiatives are positive factors. However, its dependence on the electric vehicle industry and competition in the new materials market present potential risks.

Sources & Disclaimers:

  • This overview is based on publicly available information from QIHA's website, financial filings, and industry reports.
  • The information is believed to be accurate but is not guaranteed.
  • This analysis should not be considered investment advice. Do your research before making any investment decisions.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.​

About Qilian International Holding Group Ltd

Exchange NASDAQ Headquaters -
IPO Launch date 2021-01-12 CEO -
Sector Healthcare Website https://www.qlsyy.net
Industry Drug Manufacturers - Specialty & Generic Full time employees 298
Headquaters -
CEO -
Website https://www.qlsyy.net
Website https://www.qlsyy.net
Full time employees 298

Qilian International Holding Group Limited manufactures and distributes active pharmaceutical ingredients (APIs), traditional Chinese medicine derivatives (TCMD), and other by-products in China. The company provides licorice products, including Gan Di Xin, an antitussive and expectorant medicine; Qilian Shan Licorice Extract, an ingredient for pharmaceutical companies to manufacture traditional licorice tablets; and Qilian Shan licorice liquid extract, a primary ingredient for medical preparation companies to produce compound licorice oral solutions. It offers Qilian Shan oxytetracycline tablets to prevent and treat a range of diseases in chickens, turkeys, cattle, swine, and human; and Qilian Shan oxytetracycline APIs for pharmaceutical companies to manufacture medications. In addition, the company offers TCMD products, such as Ahan antibacterial paste to treat refractory chronic skin diseases; heparin products, including heparin sodium preparations for pharmaceutical companies to produce medications for cardiovascular diseases, cerebrovascular diseases, and hemodialysis; and Zhu Xiaochang sausage casings, which are natural food products for culinary application. Further, it provides Xiongguan organic fertilizers to improve crop yield and soil's chemical properties and reduce soil compaction; and Xiongguan organic-inorganic compound fertilizers to increased plant growth. Qilian International Holding Group Limited was incorporated in 2019 and is based in Jiuquan, the People's Republic of China.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​